---
document_datetime: 2024-12-05 13:54:56
document_pages: 5
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/baqsimi-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: baqsimi-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 3.8812021
conversion_datetime: 2025-12-26 20:28:59.193483
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## BAQSIMI

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                         | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|---------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IA/0022              | A.7 - Administrative change - Deletion of manufacturing sites | 03/12/2024                          |                                             | Annex II and PL                  |           |
| IB/0021/G            | This was an application for a group of variations.            | 28/11/2024                          | n/a                                         |                                  |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|           | starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate   |            |            |                                  |                                                                                                                                                                                                                                                                       |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IAIN/0020 | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                                                                      | 23/10/2024 | n/a        |                                  |                                                                                                                                                                                                                                                                       |
| IB/0018   | B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of specification limits                                                                                                                                                                                                                                                                                                          | 21/10/2024 | n/a        |                                  |                                                                                                                                                                                                                                                                       |
| R/0015    | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                                 | 27/06/2024 | 22/08/2024 | SmPC, Annex II, Labelling and PL | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of BAQSIMI in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |
| IAIN/0017 | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                                                                      | 25/07/2024 | n/a        |                                  |                                                                                                                                                                                                                                                                       |
| IAIN/0016 | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer                                                                                                                                                                                                                                                                                         | 28/05/2024 | 22/08/2024 | Annex II and PL                  |                                                                                                                                                                                                                                                                       |

<div style=\"page-break-after: always\"></div>

|                     | responsible for importation and/or batch release - Not including batch control/testing           |            |            |                        |                                   |
|---------------------|--------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------------------------|
| T/0014              | Transfer of Marketing Authorisation                                                              | 31/01/2024 | 16/02/2024 | SmPC, Labelling and PL |                                   |
| PSUSA/10826 /202307 | Periodic Safety Update EU Single assessment - glucagon (for centrally authorised product only)   | 08/02/2024 | n/a        |                        | PRAC Recommendation - maintenance |
| PSUSA/10826 /202301 | Periodic Safety Update EU Single assessment - glucagon (for centrally authorised product only)   | 31/08/2023 | n/a        |                        | PRAC Recommendation - maintenance |
| PSUSA/10826 /202207 | Periodic Safety Update EU Single assessment - glucagon (for centrally authorised product only)   | 09/02/2023 | n/a        |                        | PRAC Recommendation - maintenance |
| PSUSA/10826 /202201 | Periodic Safety Update EU Single assessment - glucagon (for centrally authorised product only)   | 01/09/2022 | n/a        |                        | PRAC Recommendation - maintenance |
| PSUSA/10826 /202107 | Periodic Safety Update EU Single assessment - glucagon (for centrally authorised product only)   | 10/02/2022 | n/a        |                        | PRAC Recommendation - maintenance |
| PSUSA/10826 /202101 | Periodic Safety Update EU Single assessment - glucagon (for centrally authorised product only)   | 02/09/2021 | n/a        |                        | PRAC Recommendation - maintenance |
| N/0007              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification) | 18/06/2021 | 16/02/2024 | Labelling              |                                   |
| PSUSA/10826 /202007 | Periodic Safety Update EU Single assessment - glucagon (for centrally authorised product only)   | 11/02/2021 | n/a        |                        | PRAC Recommendation - maintenance |
| IA/0006/G           | This was an application for a group of variations.                                               | 02/02/2021 | n/a        |                        |                                   |

<div style=\"page-break-after: always\"></div>

| B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.c.2.a - Change in test procedure for an excipient - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.c.2.a - Change in test procedure for an excipient - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.c.2.a - Change in test procedure for an excipient - Minor changes to an approved test procedure B.II.c.2.a - Change in test procedure for an excipient - Minor changes to an approved test procedure B.II.c.2.a - Change in test procedure for an excipient   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

|                     | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                       |            |     |                                   |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| PSUSA/10826 /202001 | Periodic Safety Update EU Single assessment - glucagon (for centrally authorised product only)                                                                                                                                         | 03/09/2020 | n/a | PRAC Recommendation - maintenance |
| IAIN/0004           | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing | 06/07/2020 | n/a |                                   |
| IA/0002             | B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                                             | 17/04/2020 | n/a |                                   |